FGF23 and chronic kidney disease: This finding confirms former studies, including the ‘Heart and Soul Study’, which demonstrated an association between FGF23 and outcomes in non-CKD patients with prevalent coronary heart disease [24], and the Uppsala Longitudinal Study of Adult Men, in which FGF23 was independently associated with elevated cardiovascular mortality during a median follow-up time of 9.7 years [25].